Works matching IS 09291903 AND DT 2012 AND VI 19 AND IP 9

Results: 9

Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 659, doi. 10.1038/cgt.2012.47

By:

Reddi, H V;
Madde, P;
McDonough, S J;
Trujillo, M A;
Morris, J C;
Myers, R M;
Peng, K W;
Russell, S J;
McIver, B;
Eberhardt, N L

Publication type:

Article

Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 593, doi. 10.1038/cgt.2012.36

By:

Zarogoulidis, P;
Chatzaki, E;
Hohenforst-Schmidt, W;
Goldberg, E P;
Galaktidou, G;
Kontakiotis, T;
Karamanos, N;
Zarogoulidis, K

Publication type:

Article

Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 630, doi. 10.1038/cgt.2012.41

By:

Zhang, Z;
Hu, Z;
Gupta, J;
Krimmel, J D;
Gerseny, H M;
Berg, A F;
Robbins, J S;
Du, H;
Prabhakar, B;
Seth, P

Publication type:

Article

Effects of interferon-α-transduced tumor cell vaccines and blockade of programmed cell death-1 on the growth of established tumors.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 637, doi. 10.1038/cgt.2012.42

By:

Omori, R;
Eguchi, J;
Hiroishi, K;
Ishii, S;
Hiraide, A;
Sakaki, M;
Doi, H;
Kajiwara, A;
Ito, T;
Kogo, M;
Imawari, M

Publication type:

Article

TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 652, doi. 10.1038/cgt.2012.46

By:

Moniri, M R;
Sun, X-Y;
Rayat, J;
Dai, D;
Ao, Z;
He, Z;
Verchere, C B;
Dai, L-J;
Warnock, G L

Publication type:

Article

HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 601, doi. 10.1038/cgt.2012.38

By:

Yao, Y;
Fang, Z-P;
Chen, H;
Yue, L;
Min, D-l;
Tang, L-N;
Yu, W-X;
Kung, H F;
Lin, M C;
Shen, Z

Publication type:

Article

Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 609, doi. 10.1038/cgt.2012.39

By:

Issaenko, O A;
Bitterman, P B;
Polunovsky, V A;
Dahlberg, P S

Publication type:

Article

Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 644, doi. 10.1038/cgt.2012.45

By:

Yi, B-R;
Hwang, K-A;
Kang, N-H;
Kim, S U;
Jeung, E-B;
Kim, H-C;
Choi, K-C

Publication type:

Article

Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 9, p. 619, doi. 10.1038/cgt.2012.40

By:

Zhang, K-J;
Zhang, J;
Wu, Y-M;
Qian, J;
Liu, X-J;
Yan, L-C;
Zhou, X-M;
Xiao, R-J;
Wang, Y-G;
Cao, X;
Wei, N;
Liu, X-R;
Tang, B;
Jiao, X-Y;
Chen, K;
Liu, X-Y

Publication type:

Article